<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02274883</url>
  </required_header>
  <id_info>
    <org_study_id>6027</org_study_id>
    <nct_id>NCT02274883</nct_id>
  </id_info>
  <brief_title>The Effect of Feeding Infant Formula With Enriched Protein Fractions</brief_title>
  <official_title>The Effect of Feeding Infant Formula With Enriched Protein Fractions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mead Johnson Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Children's Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mead Johnson Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is intended to evaluate the nutritive effects of study formulas on growth and
      cognitive outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the nutritive effects of study formulas on growth and cognitive outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2014</start_date>
  <completion_date type="Actual">May 2017</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infant cognitive development</measure>
    <time_frame>At 12 months of age</time_frame>
    <description>Cognitive Scale of Bayley-III is used as the assessment tool.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infant cognitive development</measure>
    <time_frame>At 18 months of age</time_frame>
    <description>Cognitive Scale of Bayley-III is used as the assessment tool.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant language and motor skills</measure>
    <time_frame>At 4, 6, 9, 12 and 18 months of age</time_frame>
    <description>Ages and Stages Questionnaire, MacArthur-Bates Communicative Development Index, Language Scale and Motor Scale of Bayley-III are used as the assessment tool.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant acquisition of social and emotional milestones and adaptive development</measure>
    <time_frame>At 4, 6, 9, 12 and 18 months of age</time_frame>
    <description>Ages and Stages Questionnaire, social-emotional scale and adaptive behavior scale of Bayley-III are used as assessment tool.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant temperament</measure>
    <time_frame>At 12 and 18 months of age</time_frame>
    <description>Carey Scale is used as assessment tool.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant attention capabilities</measure>
    <time_frame>At 12 and 18 months of age</time_frame>
    <description>Single Object Attention and Free Play Tasks is used as assessment tool.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical development</measure>
    <time_frame>At 14, 30, 42, 60, 90, 120, 180, 275, 365, and 545 days of age</time_frame>
    <description>Body weight, length and head circumference are measured.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stool characteristics</measure>
    <time_frame>At 14, 30, 42, 60, 90, 120, 180, 275 and 365 days of age</time_frame>
    <description>According to the recall of parents during the last 24 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Formula intake</measure>
    <time_frame>At 30, 42, 60, 90, 120, 180, 275 and 365 days of age</time_frame>
    <description>According to the recall of parents during the last 24 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal microbiome and metabolome profile</measure>
    <time_frame>Average of 14 days of age and 120 days of age</time_frame>
    <description>Fecal microbiome analysis is done at average of 14 days and 120 days of age. While metabolome profile analysis is done at only average of 120 days of age.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medically-confirmed Adverse Events</measure>
    <time_frame>Up to 19 months of age</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">451</enrollment>
  <condition>Cognitive Ability, General</condition>
  <arm_group>
    <arm_group_label>Enriched Protein Fractions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group is given Infant formula with enriched protein fractions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Protein Fractions</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group is given Infant formula with protein fractions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Enriched Protein Fractions</intervention_name>
    <description>Enriched protein fractions</description>
    <arm_group_label>Enriched Protein Fractions</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Protein Fractions</intervention_name>
    <description>Protein fractions</description>
    <arm_group_label>Protein Fractions</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  10-14 days of age

          -  Exclusively formula-fed

          -  Singleton birth

          -  Gestational age of 37-42 weeks

          -  Birth weight of 2500g to 4000g

          -  Signed Informed Consent Form

        Exclusion Criteria:

          -  History of underlying metabolic or chronic disease

          -  Congenital malformation

          -  Condition which is likely to interfere with food ingestion, normal growth, development
             and evaluation

          -  Evidence of feeding difficulties or intolerance

          -  Immunocompromised

          -  Head/brain disease/injury
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Colombo, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>University of Kansas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fei Li, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Shanghai Children's Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bryan Liu, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Mead Johnson Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fuyang Fifth People's Hospital</name>
      <address>
        <city>Fuyang</city>
        <state>Anhui</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fuyang Maternal and Child Health Institute</name>
      <address>
        <city>Fuyang</city>
        <state>Anhui</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yinquan Maternal and Child Health Institute</name>
      <address>
        <city>Fuyang</city>
        <state>Anhui</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2014</study_first_submitted>
  <study_first_submitted_qc>October 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 24, 2014</study_first_posted>
  <last_update_submitted>August 31, 2017</last_update_submitted>
  <last_update_submitted_qc>August 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

